Matrix metalloproteinase3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian population

Abstract

Single nucleotide polymorphisms (SNPs) of matrix metalloproteinase3 (MMP3) promoter in the development and progression of gastric cancer of whole stomach has never been investigated in any population. We conducted a hospital-based case-control study to explore the MMP3 SNPs and their haplotypes with the risk of gastric cancer for the first time in eastern Indian population. A total of 218 gastric cancer patients and 175 healthy controls were genotyped for MMP3-1612 5A/6A (rs3025058) by PCR-RFLP and rechecked 10% by DNA sequencing. MMP3-707 A/G (rs522616) and MMP3-375C/G (rs617819) were genotyped by DNA sequencing among 209 patients and 154 controls. MMP3-1612 5A6A genotype (P=0.026, odds ratio (OR)=1.756, confidence interval (CI)=1.070-2.883), combined 5A5A and 5A6A genotype (P=0.015, OR=1.791, CI=1.122-2.858) and 5A allele (P=0.002, OR=1.75, CI=1.21-2.53) and; MMP3-707 GG genotype (P=<0.0001; OR=9.612; 95% CI=3.403-27.147), combined GG and AG genotype (P=0.001, OR=2.201, CI=1.385-3.498) and G allele (P=<0.0001, OR=2.189, CI=1.582-3.033) conferred significant risk for gastric cancer development. Also, tobacco addicted individuals with combined 5A5A and 5A6A genotype (P=0.005, OR=2.952, CI=1.377-6.327) at -1612 position of MMP3 promoter displayed a higher risk to gastric cancer development. The genotypic combinations of all three MMP3 promoter polymorphisms and their haplotypes with increasing risk allele in a dose-dependent manner showed a potential risk for developing gastric cancer. The analyses suggested that the MMP3-707 G/G and MMP3-1612 5A/6A polymorphisms are potential independent predictors of gastric cancer risk development. © 2011 Wiley Periodicals, Inc.